FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Catherine Butterfield

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Jiang Yang; Catherine Butterfield; Brendan McNeish; Marsha A Moses
Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer.
Carmen M Barnés; Catherine Butterfield; Flavia Cassiola; Deviney Chaponis; Emily R Christison-Lagay; Erica M Fallon; Judah Folkman; Mark Kieran; Hau D Le; Deepika Nehra; Dipak Panigrahy; Daniela Prox; Sarah Short; Mark Puder
Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.
Gang Liang; Jiwang Liang; Amy Birsner; Catherine Butterfield; Judah Folkman; Yuen Shing
Beta-35 is a transferrin-derived inhibitor of angiogenesis and tumor growth.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Catherine Butterfield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jiang Yang; Catherine Butterfield; Brendan McNeish; Marsha A Moses
Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(1):45-50.
2012: Carmen M Barnés; Catherine Butterfield; Flavia Cassiola; Deviney Chaponis; Emily R Christison-Lagay; Erica M Fallon; Judah Folkman; Mark Kieran; Hau D Le; Deepika Nehra; Dipak Panigrahy; Daniela Prox; Sarah Short; Mark Puder
Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.
Pediatric research 2012;71(2):168-78.
2011: Gang Liang; Jiwang Liang; Amy Birsner; Catherine Butterfield; Judah Folkman; Yuen Shing
Beta-35 is a transferrin-derived inhibitor of angiogenesis and tumor growth.
Biochemical and biophysical research communications 2011;409(3):562-6.
2008: Dipak Panigrahy; Arja Kaipainen; Sui Huang; Catherine Butterfield; Carmen M Barnés; Michael Fannon; Andrea M Laforme; Deviney M Chaponis; Judah Folkman; Mark W Kieran
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(3):985-90.
2007: Yoshito Takeda; Alexander R Kazarov; Catherine Butterfield; Benjamin D Hopkins; Laura E Benjamin; Arja Kaipainen; Martin Helmer
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro.
Blood 2007;109(4):1524-32.
2007: Arja Kaipainen; Mark W Kieran; Sui Huang; Catherine Butterfield; Diane R Bielenberg; Gustavo Mostoslavsky; Richard Mulligan; Judah Folkman; Dipak Panigrahy
PPARalpha deficiency in inflammatory cells suppresses tumor growth.
PloS one 2007;2(2):e260.
2004: Lynn K Chang; Guillermo Garcia-Cardeña; Filip Farnebo; Michael Fannon; Emy J Chen; Catherine Butterfield; Marsha A Moses; Richard C Mulligan; Judah Folkman; Arja Kaipainen
Dose-dependent response of FGF-2 for lymphangiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(32):11658-63.
2003: Cecilia A Fernández; Catherine Butterfield; Geraldine Jackson; Marsha A Moses
Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
The Journal of biological chemistry 2003;278(42):40989-95.
2002: Dipak Panigrahy; Samuel Singer; Lucy Q Shen; Catherine Butterfield; Deborah A Freedman; Emy J Chen; Marsha A Moses; Susan Kilroy; Stefan Duensing; Christopher Fletcher; Jonathan A Fletcher; Lynn Hlatky; Philip Hahnfeldt; Judah Folkman; Arja Kaipainen
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
The Journal of clinical investigation 2002;110(7):923-32.
2000: J Fang; Yuen Shing; DG Wiederschain; L Yan; Catherine Butterfield; G Jackson; J Harper; G Tamvakopoulos; Marsha A Moses
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(8):3884-9.